Melasma Treatment in Riyadh

Melasma is a form of hyperpigmentation characterized by darker patches on the skin. It commonly affects the face and occurs when melanocytes, the cells responsible for producing melanin, become more active and produce increased amounts of pigment.

Melasma is usually flat rather than raised and may appear as light brown, brown, or darker patches. The pigmentation can vary in intensity and may become more noticeable following sun exposure or hormonal changes.

Melasma is not simply a surface discoloration. Several environmental, hormonal, and individual factors can contribute to its development and persistence. Identifying these factors can therefore be important when planning treatment.

Melasma most commonly affects sun-exposed areas of the face, including:

The distribution can provide useful clinical information, although the location alone does not establish the diagnosis.

Melasma does not have one single cause. It is thought to develop through an interaction between pigment-producing cells, hormonal influences, light exposure, genetic susceptibility, and other individual factors.

Sun exposure is one of the most important factors associated with melasma.

Ultraviolet radiation can stimulate melanocytes and increase melanin production, potentially making existing pigmentation more noticeable. Repeated exposure can also make long-term pigment management more difficult.

This is why consistent photoprotection is an important part of melasma management.

Hormonal factors are associated with melasma in many patients.

Pigmentation may develop or become more noticeable during periods of hormonal change, including pregnancy. Hormonal contraceptives and other hormonal treatments may also be relevant for some individuals.

A medical history can help determine whether hormonal factors may be contributing to a patient’s pigmentation.

Some individuals may have a greater tendency to develop melasma because of genetic or individual susceptibility.

A family history of melasma may be relevant, although having a family member with melasma does not mean that another person will necessarily develop the condition.

Visible light may contribute to melasma in susceptible individuals, particularly in darker skin types. Heat and other environmental factors have also been investigated as possible contributors.

Skin irritation and inflammation may also influence pigmentation in some individuals.

Understanding potential triggers can help create a practical long-term management plan.

Melasma can be described according to the apparent depth and distribution of pigmentation.

Epidermal melasma refers to pigmentation predominantly located within the more superficial layers of the skin.

Its appearance can vary depending on the amount and distribution of pigment. Superficial pigmentation may respond differently to treatment from pigmentation involving deeper layers.

Dermal melasma involves pigment associated with deeper layers of the skin.

Its clinical appearance and response to treatment can differ from predominantly superficial pigmentation.

Some patients have features involving both superficial and deeper pigmentation, commonly described as mixed melasma.

These classifications provide useful context during assessment, but treatment decisions should consider the overall clinical picture rather than relying on pigmentation depth alone.

Centrofacial melasma primarily involves the central areas of the face, such as the forehead, cheeks, nose, and upper lip.

Malar melasma is mainly distributed across the cheeks and the upper part of the face.

Mandibular melasma involves pigmentation around the lower face or jawline.

Distribution patterns can overlap, and individual presentations do not always fit neatly into a single category.

Melasma is one type of hyperpigmentation, but not every dark patch on the face is melasma.

Post-inflammatory hyperpigmentation can develop after acne, eczema, irritation, burns, or other forms of skin inflammation. Sun spots and other pigmentation disorders may also appear as darker areas on the skin.

These conditions can require different approaches to assessment and treatment.

This distinction matters because treating pigmentation without understanding its underlying cause may produce limited results or unnecessary irritation.

If you are unsure whether facial pigmentation is melasma, a dermatological assessment can help determine the most appropriate approach.

Melasma is generally diagnosed through a clinical skin examination and detailed medical history.

A dermatologist evaluates the color, pattern, distribution, and appearance of the pigmentation.

The aim is not simply to identify darker areas but to determine whether their characteristics are consistent with melasma and whether another pigmentation condition should be considered.

The location and distribution of pigmentation can provide useful information.

A dermatologist may assess whether pigmentation is relatively symmetrical, which facial areas are involved, and whether the appearance has changed over time.

The assessment may include questions about:

This information can help identify factors that may influence management.

Previous chemical peels, laser procedures, IPL, topical products, and other treatments can affect the current condition of the skin.

Knowing what has already been used is particularly important when previous treatment caused irritation, inflammation, or changes in pigmentation.

There is no single treatment approach that is appropriate for every person with melasma.

Treatment planning may consider:

Two patients may have similar-looking pigmentation but require different management strategies.

The objective is to select an appropriate approach for the individual’s condition while minimizing unnecessary irritation and treatment-related pigmentation changes.

Melasma management may involve topical treatments, photoprotection, procedures, or a combination of approaches.

The appropriate option depends on the individual’s diagnosis, skin characteristics, treatment history, and risk factors.

Topical therapy can play an important role in managing melasma.

Depending on the patient’s circumstances, a dermatologist may consider ingredients such as hydroquinone, tretinoin or other retinoids, azelaic acid, cysteamine, or other pigment-modulating treatments.

Not every topical treatment is appropriate for every patient. Factors such as skin sensitivity, duration of treatment, pregnancy status, current medications, and previous treatment history can influence selection.

Prescription treatments should be used according to medical guidance.

Selected chemical peels may be considered as part of a melasma management plan.

Peels use controlled chemical exfoliation to affect selected layers of the skin and may help improve the appearance of certain pigmentation concerns.

The peeling agent, concentration, treatment depth, and frequency should be selected according to the patient’s skin characteristics and diagnosis.

Overly aggressive treatment can cause irritation or inflammation, which may contribute to post-inflammatory hyperpigmentation.

Certain laser or light-based procedures may be considered for selected patients with melasma or associated pigmentation concerns.

Their suitability depends on factors such as:

Laser or light-based treatment should therefore be considered as one possible component of a broader management plan rather than an automatic solution for every case of melasma.

Microneedling may be considered in selected patients, particularly when pigmentation occurs alongside certain textural concerns.

Because microneedling creates controlled micro-injuries in the skin, treatment intensity should be selected carefully for individuals who are prone to post-inflammatory hyperpigmentation.

Some patients may benefit from a combination of treatment approaches.

A management plan may include topical therapy, consistent photoprotection, and selected procedures when appropriate.

Combining approaches can address different aspects of melasma while allowing treatment to be adapted to the patient’s skin and response.

Combination treatment is not automatically required and should be individualized.

Sun protection is a fundamental part of managing melasma.

Ultraviolet exposure can stimulate pigmentation and make existing melasma more noticeable. Consistent photoprotection can therefore be important both during active treatment and as part of long-term maintenance.

A broad-spectrum sunscreen helps protect the skin against UVA and UVB radiation.

For someone managing melasma, sunscreen should be part of a daily routine rather than used only during prolonged outdoor activities.

Depending on the individual’s pigmentation and skin characteristics, a dermatologist may also discuss tinted sunscreen containing iron oxides as part of broader protection against visible light.

Visible light may influence melasma in some individuals.

Additional practical measures can include seeking shade, limiting prolonged direct sun exposure, wearing protective clothing, and using a hat when appropriate.

For patients living in Riyadh, regular exposure to strong sunlight can be an important consideration when managing pigmentation.

Consistent daily photoprotection is therefore particularly relevant for patients undergoing melasma treatment and for maintaining improvement over time.

More aggressive treatment is not necessarily better treatment for melasma.

Procedures or skincare products that cause significant irritation or inflammation may contribute to post-inflammatory hyperpigmentation in susceptible individuals.

This can make the overall pigmentation concern more noticeable.

Treatment planning should therefore consider the patient’s skin characteristics, previous procedures, sensitivity, current inflammation, and risk of pigmentation changes.

A carefully selected and appropriately timed treatment plan may be preferable to repeatedly using increasingly aggressive procedures.

Melasma can be recurrent, meaning pigmentation may become noticeable again after a period of improvement.

Treatment can reduce existing pigmentation, but factors associated with melasma may continue to be present. Sun exposure, hormonal influences, genetic susceptibility, visible light, and other individual triggers may contribute to recurrence.

Long-term management may therefore include:

The goal is not simply to reduce visible pigmentation at one point in time but to develop a sustainable approach to managing a condition that can recur.

The first step is understanding your pigmentation, medical history, previous treatments, skin characteristics, and individual concerns.

Based on the assessment, a dermatologist can determine which treatment approaches may be appropriate and whether more than one strategy should be considered.

The number and frequency of treatment sessions vary according to the treatment selected and the individual’s response.

Melasma treatment benefits from monitoring because the skin can respond differently over time.

Follow-up allows the treatment plan to be adjusted according to pigmentation changes, skin tolerance, and overall response.

Improvement in melasma can be gradual, and results vary between individuals.

Factors such as pigmentation pattern, skin characteristics, trigger exposure, treatment approach, and consistency with the recommended management plan can influence the response.

Melasma treatments can have potential side effects or limitations depending on the approach used.

Possible effects may include:

Topical medications can also have specific precautions and side effects.

Medical history, current medications, pregnancy status where relevant, and skin sensitivity should be considered before treatment is recommended.

If significant irritation or unexpected pigmentation changes develop, medical review may be appropriate.

Melasma treatment may be considered for individuals whose facial pigmentation has been clinically assessed as consistent with melasma and who are seeking improvement.

Suitability depends on factors such as:

A consultation allows these factors to be considered before deciding which treatment approach, if any, is appropriate.

Dr. Haitham Al-Gzlan approaches melasma treatment through individualized assessment rather than using the same procedure for every patient.

The evaluation considers the appearance and distribution of pigmentation, possible contributing factors, skin characteristics, previous treatments, and treatment goals.

Depending on the assessment, management may include topical treatment, photoprotection, selected procedures, or a combination of approaches when appropriate.

For patients seeking melasma treatment in Riyadh, the focus is on understanding the condition, selecting treatment carefully, and considering long-term management.

If you are concerned about facial pigmentation or possible melasma, a dermatological assessment can help determine the nature of the pigmentation and identify appropriate management options.

Dr. Haitham Al-Gzlan can assess your pigmentation, skin characteristics, previous treatments, and individual factors before discussing a personalized treatment plan.

Book a melasma consultation in Riyadh to discuss your pigmentation concerns and treatment options.